156
Participants
Start Date
November 16, 2021
Primary Completion Date
November 1, 2022
Study Completion Date
November 8, 2022
MT-8554
Oral Capsule
Placebo
Oral Capsule
Yachiyo Hospital, Anjo
Japan Organization of Occupational Health and Safety Chubu Rosai Hospital, Nagoya
JUNEIKAI Medical Corporation Akaicho Clinic, Chiba
Social Medical Corporation the Chiyukai foundation Fukuoka Wajiro Hospital, Fukuoka
TOJITAMA thyroid and diabetes Clinic, Fukuoka
Kunisaki Makoto Clinic, Fukuoka
Steel Memorial Yawata Hospital, Kitakyushu-shi
Medical Corporation Kouhoukai Takagi Hospital, Okawa-shi
Matsunami Health Promotion Clinic, Hashima-gun
Kikuchi Clinic of Internal Medicine, Maebashi
Japanese Red Cross Asahikawa Hospital, Asahikawa
Hakodate Central General Hospital, Hakodate
Jiyugaoka Yamada Internal Medicine Clinic, Obihiro
Sanuki Municipal Hospital, Sanuki-shi
Takamatsu Red Cross Hospital, Takamatsu
Shonan Fujisawa Tokushukai Hospital, Fujisawa-shi
Shunkaikai Inoue Hospital, Nagasaki
Medical Corporation Keiaikai Nakamura Hospital, Beppu
Medical Corporation Ikeikai Inobe Funai Clinic, Ōita
Abe Diabetes Clinic, Ōita
Saiki Central Hospital, Saiki
Medical Corporation Heishinkai OCROM Clinic, Suita
Hisatomi Clinic, Saga
Soka Sugiura Internal Medicine Clinic, Sōka
OMI MEDICAL CENTER, Social Medical Corporation Seikoukai, Kusatsu
Kumanomae Nishimura Naika Clinic, Arakawa-ku
Tokyo Center Clinic, Chuo-ku
Sugawara Clinic, Nerima-ku
Ome Municipal General Hospital, Ome-shi
Medical Corporation Souaikai Aihara Medical Clinic, Shinagawa-ku
Medical Corporation Heishinkai ToCROM Clinic, Shinjuku-ku
Japan Organization of Occupational Health and Safety Sanin Rosai Hospital, Yonago
Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka
Lead Sponsor
Mitsubishi Tanabe Pharma Corporation
INDUSTRY